The FDA wants to know how physician attitudes towards direct-to-consumer advertising have evolved since the agency last asked them, in 2002. If a snap poll by CMI/Compas is any indication, drug companies probably won't like the answers.
WebMD executed a cross-platform magazine redesign with a more visual and celeb-centric new look.
WebMD the Magazine is now part of the iPad app world.
Procter & Gamble is looking to lower its promotion costs by leaning more on digital media, Chairman and CEO Bob McDonald told analysts in an earnings call.
Novo Nordisk is courting controversy with a Victoza-branded type 2 diabetes education campaign featuring Southern-fried celebrity chef Paula Deen and her sons.
A print ad for Genentech's Boniva overstated the osteoporosis drug's efficacy, said the FDA's Division of Drug Marketing, Advertising and Communication in an untitled letter.
Novo Nordisk launched a consumer campaign for Victoza, emphasizing the product's ability to bring down blood sugar levels and body weight in patients with type 2 diabetes. The campaign features print ads and a refurbished website, and marks the first consumer push for the brand since its approval in January.
Drug ads emphasizing familial health risks prompt at-risk patients to adjust their lifestyles, not just pop a pill, a study found.
AstraZeneca launched the first consumer TV and print ads for Seroquel XR for bipolar depression, playing on the all-consuming way in which patients experience the disease.
Pfizer boosted ad spend 12% for the first nine months of 2009 over the same period in 2008, even as ad spend for the sector remained static and spending across all sectors plummeted 14.7%, according to TNS Media Intelligence.
US advertising spend for prescription drugs declined 7.8% to $2.3 billion for the first six months of 2009 over the same period in 2008, according to TNS Media Intelligence data.
Wyeth is cranking up consumer advertising for Pristiq with spots that aim to capture depression sufferers' struggle to get through the day, as represented by an iconic wind-up doll.
If you still haven't entered the MM&M Awards 2009, then you'd better move fast--today (June 5) is the final deadline for submissions.
The presence of information on serious side effects in the brief summaries of print DTC drug ads seems to have little effect on reader behavior, preliminary results of an FDA study show. The age and health literacy of readers, on the other hand, had a measurable impact.
Pharmaceutical industry ad spend fell 18.4% in 2008 to $4.3 billion in the US, according to The Nielsen Company. J&J, the sole drug company among the nation's top 10 advertisers, spent $1.2 billion on advertising -- a drop of 5.4% from 2007 spend.
Wyeth Consumer Health has launched a TV and print ad campaign for Advil advising consumers that they can do more with fewer bottles of OTC pain meds clogging up their purses, thanks to "The Every Pain Reliever."
Print and TV ads for ED drugs should appear only in programs or publications with an adult audience of 90% or more under revised PhRMA consumer advertising guidelines -- in the original version, released in August 2005, the baseline was 80% -- and signatory company CEOs and chief compliance officers must sign an annual certification stating that they have policies and procedures in place to foster compliance with the principles.
Spending on direct-to-consumer launch campaigns fell significantly this year as companies waited longer to market fewer new drugs with more limited indications, said a TNS Media Intelligence report.
Medical Economics has hired five new senior-level editors, and relocated its offices to Cleveland, Ohio.
All the fury over DTC drug ads emanating from Washington hasn't dented their credibility with consumers, according to Rodale's 11th Annual Survey on Consumer Reaction to DTC Advertising of Prescription Drugs.
AstraZeneca is going for the jugular - or rather, the carotid - with new ads emphasizing Crestor's effectiveness at slowing the progression of atherosclerosis.
Intellisphere owner MJH & Associates may continue operating Family Practice Recertification, Internal Medicine World Report and Physician's Money Digest as online-only properties, but will cease print publication of the titles due to the weakness in the advertising market for primary care journals.
Ascend Media has sold its struggling medical titles to Intellisphere for an undisclosed sum.
Advanstar has named Formulary publisher Trevor Deal to lead Medical Economics.
Mary Lou Retton is returning to TV advertising for device manufacturer Biomet's Oxford Partial Knee System.
Mary Ann Kim has joined MediZine as senior marketing manager, brand services from AWE, an entertainment marketing agency under Omnicom, where she was responsible for aligning strategic partnerships between clients and consumer brands, as well as business development.
Haymarkets Clinical Advisor won a Folio: Magazine Eddie Gold Award as best business-to-business publication in Healthcare/Medical/Nursing, trumping Advance for Healthy Aging, Dental Practice Report and Government Health.
What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.
A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.